Clinical trials
Phase 1/2 Leukemia, B-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| AVM Biotechnology Inc | 1 |
| AbbVie (prior sponsor, Abbott) | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Bristol-Myers Squibb | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| National Cancer Institute (NCI) | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Ossium Health, Inc. | 1 |
| Pharmacyclics LLC. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 13 |
| Leukemia | 7 |
| Lymphoma, B-Cell | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma | 5 |
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Recurrence | 4 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.